Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Asthma
Interventions
DRUG

epinephrine inhalation aerosol

Single dose 220 mcg/inhalation, 10 inhalations

DRUG

epinephrine inhalation aerosol

HFA propelled epinephrine inhalation aerosol, 125 mcg/inhalation, 10 inhalations

DRUG

epinephrine inhalation aerosol

HFA propelled epinephrine inhalation aerosol, 160 mcg/inhalation, 10 inhalations

Trial Locations (1)

90630

Amphastar Location 1, Cypress

All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY